Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$468M |
| 2 |
Johnson & Johnson
JNJ
|
+$440M |
| 3 |
IBM
IBM
|
+$355M |
| 4 |
Booking.com
BKNG
|
+$332M |
| 5 |
RAI
Reynolds American Inc
RAI
|
+$331M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
LLTC
Linear Technology Corp
LLTC
|
+$482M |
| 2 |
Walt Disney
DIS
|
+$247M |
| 3 |
Visa
V
|
+$219M |
| 4 |
Deere & Co
DE
|
+$200M |
| 5 |
Johnson Controls International
JCI
|
+$179M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.02% |
| 2 | Technology | 13.31% |
| 3 | Financials | 12.25% |
| 4 | Industrials | 9.65% |
| 5 | Consumer Staples | 9.54% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1526
Ambev
ABEV
$43.8B
| $6.39M | 0.01% |
1,109,200
-9,564,819
| -90% | -$52.5M |
|
|
IVAC
1527
DELISTED
Intevac Inc
IVAC
| $6.38M | 0.01% |
510,485
+135,632
| +36% | +$1.38M |
|
|
EMCI
1528
DELISTED
EMC INS Group Inc
EMCI
| $6.38M | 0.01% |
227,372
+12,422
| +6% | +$357K |
|
1529
MaxLinear
MXL
$6.95B
| $6.37M | 0.01% |
226,952
-244,761
| -52% | -$6.28M |
|
|
CDI
1530
DELISTED
CDI Corp.
CDI
| $6.36M | 0.01% |
744,300
+26,400
| +4% | +$224K |
|
|
ESSA
1531
DELISTED
ESSA Bancorp
ESSA
| $6.34M | 0.01% |
434,900
+38,600
| +10% | +$603K |
|
|
LL
1532
DELISTED
LL Flooring Holdings, Inc.
LL
| $6.34M | 0.01% |
+302,000
| New | +$5.13M |
|
|
CEMP
1533
DELISTED
Cempra, Inc.
CEMP
| $6.3M | 0.01% |
1,680,500
+1,069,300
| +175% | +$3.71M |
|
|
GMLP
1534
DELISTED
Golar LNG Partners LP
GMLP
| $6.29M | 0.01% |
281,517
+252,912
| +884% | +$5.83M |
|
|
MPG
1535
DELISTED
Metaldyne Performance Group Inc.
MPG
| $6.26M | 0.01% |
274,100
-195,600
| -42% | -$4.56M |
|
1536
InterContinental Hotels
IHG
$23.5B
| $6.25M | 0.01% |
116,104
-10,096
| -8% | -$522K |
|
|
CNCE
1537
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $6.22M | 0.01% |
364,800
-71,000
| -16% | -$852K |
|
|
WRI
1538
DELISTED
Weingarten Realty Investors
WRI
| $6.18M | 0.01% |
185,232
+126,532
| +216% | +$4.42M |
|
|
ACH
1539
DELISTED
Alum Corp of China Ltd
ACH
| $6.17M | 0.01% |
508,800
+48,700
| +11% | +$606K |
|
1540
Celldex Therapeutics
CLDX
$3.35B
| $6.17M | 0.01% |
113,862
+33,881
| +42% | +$1.76M |
|
|
MN
1541
DELISTED
MANNING & NAPIER, INC.
MN
| $6.16M | 0.01% |
1,080,600
+17,500
| +2% | +$115K |
|
1542
Compass Minerals
CMP
$1.1B
| $6.14M | 0.01% |
90,500
+72,000
| +389% | +$5.49M |
|
|
EGIO
1543
DELISTED
Edgio, Inc. Common Stock
EGIO
| $6.14M | 0.01% |
59,455
+628
| +1% | +$58.7K |
|
1544
CBIZ
CBZ
$2.96B
| $6.13M | 0.01% |
452,657
+89,243
| +25% | +$1.2M |
|
1545
Winnebago Industries
WGO
$921M
| $6.13M | 0.01% |
209,400
-233,769
| -53% | -$7.46M |
|
1546
Plains All American Pipeline
PAA
$16.5B
| $6.12M | 0.01% |
+193,514
| New | +$6.12M |
|
1547
Malibu Boats
MBUU
$573M
| $6.11M | 0.01% |
272,300
+2,724
| +1% | +$55.1K |
|
|
NCIT
1548
DELISTED
NCI, Inc.
NCIT
| $6.09M | 0.01% |
404,799
+20,074
| +5% | +$282K |
|
1549
Simulations Plus
SLP
$370M
| $6.05M | 0.01% |
515,000
+33,700
| +7% | +$340K |
|
1550
East-West Bancorp
EWBC
$18.6B
| $6.05M | 0.01% |
117,233
+43,100
| +58% | +$2.26M |
|
Similar funds
Jim Simons's Q1 2017 Portfolio in Review
As of Q1 2017, Jim Simons held 3,652 positions worth $71.6B, up 13% from $63.2B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.
Jim Simons deployed $5.19B of net new capital in Q1 2017, opening 433 new positions and adding to 1,585 existing holdings. Its largest new stake was Merck: 7,716,460 shares worth $468M.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 12% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Walt Disney, an estimated $247M trimmed.
- Jim Simons's largest Q1 2017 buy was Merck: 7,716,460 shares worth $468M.
- Jim Simons added most to Johnson & Johnson in Q1 2017, an estimated $440M increase.
- Jim Simons's biggest Q1 2017 reduction was Walt Disney, cutting an estimated $247M.
- Jim Simons fully exited Linear Technology Corp in Q1 2017, selling an estimated $482M.
- Jim Simons's ten largest holdings make up 7.9% of its $71.6B portfolio in Q1 2017.
- Jim Simons opened 433 new positions and closed 462 in Q1 2017.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $71.6B.
Based on Renaissance Technologies's 13F filing for Q1 2017, filed 12 May 2017.